Comparing Semaglutide vs Tirzepatide for Weight Loss in Adults with Obesity: JAMA Study Anshika Mishra10 July 2024 8:00 AM ISTIn a study published in the journal JAMA Internal Medicine, researchers analysed how weight loss differs between patients receiving tirzepatide...
SGLT2 inhibitors and GLP1 receptor agonists combo tied to additional heart and kidney benefits: Lancet Dr. Kamal Kant Kohli9 July 2024 8:15 PM ISTNew research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is...
Glipizide in T2DM Care - Latest Update from ADA 2024 MD Brand Connect9 July 2024 12:08 PM ISTThe 84th Scientific Sessions of the American Diabetes Association, held in Orlando, Florida, from June 21 to June 24, 2024, featured significant...
Mediterranean and DASH diets may reduce CVD risk among adults with type 1 diabetes, reveals study Dr. Kamal Kant Kohli9 July 2024 10:00 AM ISTChicago: Eating patterns that align with the Mediterranean diet or the dietary approaches to stop hypertension (DASH) diet could help lower...
Bariatric surgery may reduce hypothalamic inflammation and modulate weight loss response: Study Medha Baranwal9 July 2024 9:45 AM ISTSpain: Recent research has shed light on promising findings regarding the impact of bariatric surgery on hypothalamic inflammation and its correlation...
Could Daily Sauna Sessions Prevent Menopausal Weight Gain? Study Sheds Light Anshika Mishra9 July 2024 8:00 AM ISTNew research, presented at NUTRITION 2024 — the annual meeting of the American Society for Nutrition— highlighted heat treatments as a method to...
Artemisinins Show Promise in Treating PCOS Through LONP1-CYP11A1 Interaction: Study Medha Baranwal8 July 2024 8:15 PM ISTChina: Recent research has unveiled a potential new avenue for treating polycystic ovarian syndrome (PCOS) using artemisinins, compounds traditionally...
GLP-1 receptor agonists show potential in reducing obesity-associated cancers among type 2 diabetes patients: JAMA Medha Baranwal8 July 2024 9:45 AM ISTUSA: The cohort study of more than 1.6 million patients with type 2 diabetes (T2D) with no prior diagnosis of 13 obesity-associated cancers (OACs)...
Sugary Iceberg of Prediabetes and Metformin's Role in Preventing Progression to T2D: Latest Meta-Analysis Dr. Kamal Kant Kohli6 July 2024 10:00 AM ISTMetformin reduced the risk of progression to diabetes by 22% in a large population of high-risk individuals with prediabetes, a new meta-analysis...
Strict Glycemic Control Can Reduce Complications in Childhood-Onset Type 1 Diabetes Patients, finds study Jacinthlyn Sylvia6 July 2024 9:45 AM ISTA recent study published in the Diabetes/Metabolism Research and Reviews illuminated the significant impact of long-term blood sugar control on the...
Semaglutide Shines in Kidney Health Across Diabetes Patients: Study Highlights Consistency and Potential Medha Baranwal5 July 2024 9:15 AM ISTGermany: A recent clinical trial, known as the FLOW trial, has provided significant insights into treating type 2 diabetes and chronic kidney disease...
Popular weight loss drug Semaglutide linked to uncommon blinding condition, reveals JAMA study Dr. Kamal Kant Kohli4 July 2024 7:30 PM ISTInvestigators at Mass Eye and Ear have found in a new study have found that patients who were prescribed semaglutide for diabetes or weight loss...
